Letters |
The Lister Hospital, Chelsea Bridge Road, London SW1W 8RH, UK
E-mail: jscurr{at}uk-consultants.co.uk
The medicolegal implications of the Rashid et al. findings need to be considered by the DVT-unaware clinicians in this study.1 There have been medico-legal claims in surgical patients resulting from a failure to provide venous thromboembolism (VTE) prophylaxis that have been settled in favour of the Claimant.2,3 These were successful when it was shown that a patient with identifiable risk factors, who developed a DVT/PE following surgery, had not undergone risk assessment and/or received appropriate prophylaxis. Although Rashid et al. have not stated whether any of their study group went onto develop a DVT/PE, it has been reported that 10% of hospital deaths are a result of VTE; and that many of these should be preventable deaths.4
Only 30% of medical patients in the high-risk group (which includes history of previous VTE) reported received prophylaxis! Potential claims from medical patients who developed an in-hospital VTE could be difficult to defend if they were not undergoing VTE risk assessment and did not receive appropriate prophylaxis. This should be considered by the DVT-unaware clinicians.
Footnotes
Competing interests JHS is involved in the development of a food supplement, zinapin, for preventing travel thrombosis.
REFERENCES
This article has been cited by other articles:
![]() |
M. Dziadzio, R. Smith, and A. Keat Challenges from the digital revolution. J R Soc Med, March 1, 2006; 99(3): 106 - 106. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||